|
TMTC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.522600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.852800E-01 |
| Normal-vs-Stage2 |
7.438000E-01 |
| Normal-vs-Stage3 |
2.724800E-01 |
| Normal-vs-Stage4 |
5.324400E-01 |
| Stage1-vs-Stage2 |
6.339000E-01 |
| Stage1-vs-Stage3 |
2.440800E-01 |
| Stage1-vs-Stage4 |
5.709600E-01 |
| Stage2-vs-Stage3 |
5.430600E-01 |
| Stage2-vs-Stage4 |
6.454600E-01 |
| Stage3-vs-Stage4 |
9.895400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.712360E-01 |
| Normal-vs-AfricanAmerican |
1.513790E-01 |
| Normal-vs-Asian |
1.1218999951268E-08 |
| Caucasian-vs-AfricanAmerican |
5.002000E-02 |
| Caucasian-vs-Asian |
5.62130000325567E-08 |
| AfricanAmerican-vs-Asian |
4.41589999999881E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.364600E-01 |
| Normal-vs-Female |
5.333400E-01 |
| Male-vs-Female |
5.177200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.240600E-01 |
| Normal-vs-Extreme_Weight |
1.040780E-01 |
| Normal-vs-Obese |
5.376800E-01 |
| Normal-vs-Extreme_Obese |
8.464400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.601400E-01 |
| Normal_Weight-vs-Obese |
2.839800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.574600E-01 |
| Extreme_Weight-vs-Obese |
1.306950E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.562600E-01 |
| Obese-vs-Extreme_Obese |
9.521000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.904200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.840200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.820000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.025800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.803800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.473200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.015800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.298200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.101300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.556000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.709600E-01 |
| Normal-VS-Type2 PRCC |
6.641000E-01 |
| Normal-VS-KIRP CIMP |
7.541400E-01 |
| Normal-VS-Unclassified PRCC |
5.859600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.453200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.915200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.474000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.677600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.398600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.980600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.364000E-03 |
| Normal-vs-N1 |
1.961740E-02 |
| Normal-vs-N2 |
6.974600E-01 |
| N0-vs-N1 |
9.347200E-01 |
| N0-vs-N2 |
4.323000E-01 |
| N1-vs-N2 |
4.271000E-01 |
|
|
